Who owns the AXOVIA THERAPEUTICS trademark?

The AXOVIA THERAPEUTICS trademark is owned by Jaguar Gene Therapy, LLC.

What class is the AXOVIA THERAPEUTICS trademark registered in?

The AXOVIA THERAPEUTICS trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for AXOVIA THERAPEUTICS?

The USPTO serial number for AXOVIA THERAPEUTICS is 90032649.

What is the registration number for AXOVIA THERAPEUTICS?

AXOVIA THERAPEUTICS is registered under USPTO registration number 6840057.

Sealvo

Home Search: AXOVIA THERAPEUTICSAXOVIA THERAPEUTICS #90032649

Back

Updated Oct 23, 2026·40 searches this week

View on USPTO TSDR Find similar marks

AXO

USPTO Trademark Record

REGISTERED

AXOVIA THERAPEUTICS

SN 90032649·Reg 6840057·Filed Jul 02, 2020

Owner Jaguar Gene Therapy, LLC

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

AXOVIA THERAPEUTICS (Serial No. 90032649), Registration No. 6840057, is a registered US trademark filed on Jul 02, 2020 by Jaguar Gene Therapy, LLC. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: September 06, 2028

Mark Intelligence

AXOVIA THERAPEUTICS (Reg. #6840057) is a registered US trademark that has been protecting its owner, Jaguar Gene Therapy, LLC, since 2020. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jul 02, 2020

SERIAL

90032649

REG#

6840057

REGISTERED

Sep 06, 2022

Filing Information

StatusREGISTERED

Filing DateJul 02, 2020

Serial Number90032649

Registration No.6840057

Registration DateSep 06, 2022

Status DateSep 06, 2022

Published for OppositionDec 01, 2020

Filing Basis & Declarations

Standard Characters ClaimedUse Application Currently

International Filings

Madrid Protocol2 filings

This mark has 2 Madrid Protocol filings on record with the USPTO.

1575198

480Dec 23, 2020

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Feb 25, 2021

First use in commerce: Feb 25, 2021

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

32 events

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Sep 06, 2022

NOTICE OF REGISTRATION CONFIRMATION EMAILED

REGISTERED-PRINCIPAL REGISTER

Sep 06, 2022

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Aug 02, 2022

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Aug 01, 2022

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 26, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 3 GRANTED

Jul 25, 2022

SOU EXTENSION 3 GRANTED

STATEMENT OF USE PROCESSING COMPLETE

Jul 25, 2022

STATEMENT OF USE PROCESSING COMPLETE

USE AMENDMENT FILED

Jul 22, 2022

USE AMENDMENT FILED

SOU TEAS EXTENSION RECEIVED

Jul 22, 2022

SOU TEAS EXTENSION RECEIVED

TEAS STATEMENT OF USE RECEIVED

Jul 22, 2022

TEAS STATEMENT OF USE RECEIVED

SOU EXTENSION 3 FILED

Jul 22, 2022

SOU EXTENSION 3 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 03, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Feb 02, 2022

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU EXTENSION 2 GRANTED

Feb 02, 2022

SOU EXTENSION 2 GRANTED

SOU TEAS EXTENSION RECEIVED

Jan 25, 2022

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Jan 25, 2022

SOU EXTENSION 2 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 24, 2021

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Jul 22, 2021

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Jul 22, 2021

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Jul 22, 2021

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jan 26, 2021

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 01, 2020

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

PUBLISHED FOR OPPOSITION

Dec 01, 2020

PUBLISHED FOR OPPOSITION

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Nov 11, 2020

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 26, 2020

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINER'S AMENDMENT ENTERED

Oct 13, 2020

EXAMINER'S AMENDMENT ENTERED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Oct 13, 2020

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINERS AMENDMENT E-MAILED

Oct 13, 2020

EXAMINERS AMENDMENT E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Oct 13, 2020

EXAMINERS AMENDMENT -WRITTEN

ASSIGNED TO EXAMINER

Oct 08, 2020

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 29, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jul 06, 2020

NEW APPLICATION ENTERED

Other Marks by Jaguar Gene Therapy, LLC

Additional USPTO filings from the same owner.

ADV

ADVANCED MEDICINE PARTNERS

98360100

JAGUAR GENE THERAPY, LLC

REGISTERED

ADV

ADVANCED MEDICINE PARTNERS

98377390

JAGUAR GENE THERAPY, LLC

REGISTERED

AXO

AXOVIA THERAPEUTICS

90546496

Jaguar Gene Therapy, LLC

REGISTERED

JAG

JAGUAR GENE THERAPY

90049793

Jaguar Gene Therapy, LLC

REGISTERED

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

AXO

AXOVIA THERAPEUTICS

90546496

Jaguar Gene Therapy, LLC

REGISTERED

VIM

VIMA THERAPEUTICS

98166904

Vima Therapeutics, Inc.

REGISTERED

SAP

SAPIENCE THERAPEUTICS

86872810

Sapience Therapeutics, Inc.

REGISTERED

KEE

KEENOVA THERAPEUTICS

79445783

Mallinckrodt Pharmaceuticals Ireland Limited

REGISTERED

Other Marks by J. Dickson Phillips, III

Additional USPTO filings handled by the same attorney of record.

SIT

SITEBRIDGE RESEARCH

97414930

REGISTERED

SIT

SITEBRIDGE RESEARCH

97415000

REGISTERED

TRI

TRIAL IN A BOX

97420768

REGISTERED

THE

THE ASSOCIATION OF BOARDING SCHOOLS

76586831

REGISTERED

AXOVIA THERAPEUTICS

Run a conflict check

Other Marks by Jaguar Gene Therapy, LLC

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by J. Dickson Phillips, III

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company